Bile Duct Cancer Treatment and Research
Bile Duct Cancer is a common type of malignant tumor of the biliary tract, starting from Cholangiocarcinoma (CAA) of the hilar region, characterized by an insidious onset, and is a prevalent malignant tumor in the biliary tract. Its diagnosis and treatment encompass multiple aspects, including epide...
সংরক্ষণ করুন:
| বিন্যাস: | Online |
|---|---|
| ভাষা: | ইংরেজি |
| প্রকাশিত: |
IntechOpen
2026
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | 3049-8864 |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|
| _version_ | 1869516460502548480 |
|---|---|
| collection | Directory of Open Access Books |
| description | Bile Duct Cancer is a common type of malignant tumor of the biliary tract, starting from Cholangiocarcinoma (CAA) of the hilar region, characterized by an insidious onset, and is a prevalent malignant tumor in the biliary tract. Its diagnosis and treatment encompass multiple aspects, including epidemiology, clinical evaluation, imaging studies, pathological classification, staging, resectability assessment, perioperative management, surgical decision-making, systemic therapy, and follow-up monitoring. The contents of the book include the following chapters: 1. Bile Duct Cancer: From Bench to Bedside – Latest Developments offers a discussion on the latest treatment strategies and research developments for this challenging biliary tract cancer. 2. Cholangiocarcinoma – A Comprehensive Review of Diagnostic Challenges and Novel Therapeutic Approaches offers an exploration of bile duct cancer research, blending scientific rigor with accessibility. 3. Diagnosis, Imaging, and Prognostic Evaluation in Cholangiocarcinoma provides a comprehensive exploration of CCA. 4. Multiomics Approaches for the Identification of Biomarkers and Therapeutic Targets in Cholangiocarcinoma dives into the integration of genomics, transcriptomics, epigenomics, proteomics, and metabolomics, unveiling a comprehensive molecular landscape of CCA. 5. Optimising Therapeutic Options for Bile Duct Cancer in the Era of Molecular Profiling, Immunotherapy and Pharmacogenomics engages readers by exploring the latest strategies to enhance cholangiocarcinoma treatment. |
| format | Online |
| id | doab-20.500.12854ir-171979 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2026 |
| publishDateRange | 2026 |
| publishDateSort | 2026 |
| publisher | IntechOpen |
| publisherStr | IntechOpen |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1719792026-02-12T17:40:26Z Bile Duct Cancer Treatment and Research Yan, Qiang Cen, Feng Medical / Diseases Medical / Nosology thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders Bile Duct Cancer is a common type of malignant tumor of the biliary tract, starting from Cholangiocarcinoma (CAA) of the hilar region, characterized by an insidious onset, and is a prevalent malignant tumor in the biliary tract. Its diagnosis and treatment encompass multiple aspects, including epidemiology, clinical evaluation, imaging studies, pathological classification, staging, resectability assessment, perioperative management, surgical decision-making, systemic therapy, and follow-up monitoring. The contents of the book include the following chapters: 1. Bile Duct Cancer: From Bench to Bedside – Latest Developments offers a discussion on the latest treatment strategies and research developments for this challenging biliary tract cancer. 2. Cholangiocarcinoma – A Comprehensive Review of Diagnostic Challenges and Novel Therapeutic Approaches offers an exploration of bile duct cancer research, blending scientific rigor with accessibility. 3. Diagnosis, Imaging, and Prognostic Evaluation in Cholangiocarcinoma provides a comprehensive exploration of CCA. 4. Multiomics Approaches for the Identification of Biomarkers and Therapeutic Targets in Cholangiocarcinoma dives into the integration of genomics, transcriptomics, epigenomics, proteomics, and metabolomics, unveiling a comprehensive molecular landscape of CCA. 5. Optimising Therapeutic Options for Bile Duct Cancer in the Era of Molecular Profiling, Immunotherapy and Pharmacogenomics engages readers by exploring the latest strategies to enhance cholangiocarcinoma treatment. 2026-02-12T17:40:23Z 2026-02-12T17:40:23Z 2025 book 3049-8864 9781836348771 9781836348788 9781836348795 https://directory.doabooks.org/handle/20.500.12854/171979 eng Oncology image/jpeg n/a https://www.intechopen.com/books/1004913 https://intech-files.s3.amazonaws.com/a04Tc00000Dsh0eIAB/0016817_Authors_Book%20%282025-11-17%2008%3A17%3A22%29.pdf IntechOpen IntechOpen 10.5772/intechopen.1009044 10.5772/intechopen.1009044 78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6 9781836348771 9781836348788 9781836348795 IntechOpen 8 96 open access |
| spellingShingle | Medical / Diseases Medical / Nosology thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders Bile Duct Cancer Treatment and Research |
| title | Bile Duct Cancer Treatment and Research |
| title_full | Bile Duct Cancer Treatment and Research |
| title_fullStr | Bile Duct Cancer Treatment and Research |
| title_full_unstemmed | Bile Duct Cancer Treatment and Research |
| title_short | Bile Duct Cancer Treatment and Research |
| title_sort | bile duct cancer treatment and research |
| topic | Medical / Diseases Medical / Nosology thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders |
| topic_facet | Medical / Diseases Medical / Nosology thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders |
| url | 3049-8864 |